drugset / Trial / NCT04320030
[18F]-DPA-714 PET/CT (Positron Emission Tomography/Computerized Tomography) in Triple Negative Breast Cancers
NaSingle-groupOpen-labelDiagnostic
Summary
This phase II study is assessing the correlation between M1/M2 macrophage polarization determined by tumor immunohistochemistry analysis and \[18F\]DPA-714 PET/CT binding (qualitative and texture analysis) in patients with operable triple negative breast cancer.
Timeline
- Start
- 2020-06-11
- Primary completion
- 2021-07-21
- Completion
- 2021-07-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]DPA-714 | Diagnostic / imaging agent | 3 mbq/kg | Intravenous |